Starting August 1, 2024, Quickarrays, Inc. will be providing all products and services in place of Pantomics Inc.
SERVICES
CUSTOM TMA
ROUTINE PATHOLOGY
IHC / IMMUNOFLUORESCENCE
ISH / FISH
CONTRACTED SERVICES
PRIMARY IHC ANTIBODIES
PATHOLOGY FIELD
Hermatopathology
DETECTION SYSTEMS
ANCILLARIES
CONTROL TMA
OVC962
Ovary cancer tissue array, set 2, non-overlapping with OVC962, 96 cores, 48 cases from normal, premalignant and cancer tissues with progressive grades and TNM stages in duplicates.
Specification
Data Sheet
TNM Grading
Downloads
Price
Size
Availability
$307
1 slide
In-Stock
A | |
B | |
C | |
D | |
E | |
F | |
G | |
H | |
TNM Classification: Ovary carcinoma
T- Primary tumor
TX - Primary tumor cannot be assessed
TO - No evidence of primary tumor
T1 - Tumor limited to the ovaries
T1a - Tumor limited to one ovary; capsule intact, no tumor invasion on ovarian surface; no malignant cells in ascites or peritoneal washings
T1b - Tumor limited to both ovaries; capsule intact, no tumor invasion on ovarian surface; no malignant cells in ascites or peritoneal washings
T1c - Tumor limited to one or both ovaries with any or the following features; capsule ruptured, tumor on ovarian surface, malignant cells in ascites or peritoneal washing
T2 - Tumor involves one or both ovaries with pelvic extension
T2a - Extension and/or implants on uterus and/or tube(s); no malignant cells in ascites or peritoneal washings
T2b - Extension to other pelvic tissue; no malignant cells in ascites or peritoneal washings
T2c - Pelvic extension (T2a or T2b) with malignant cells in ascites or peritoneal washings
T3 and/or N1 - Tumor involves both ovaries with microscopically confirmed peritoneal metastasis outside the pelvis and/or regional lymph node metastasis
T3a - Microscopic peritoneal metastasis beyond pelvis
T3b - Macroscopic peritoneal metastasis beyond pelvis 2 cm or less in greatest dimension
T3c and/or N1 - Peritoneal metastasis beyond pelvis more than 2 cm in greatest dimension and/or regional lymph node metastasis
N - Regional lymph nodes
NX - Regional lymph nodes cannot be assessed
NO - No regional lymph node metastasis
N1 - Regional lymph node metastasis
M - Distant metastasis
MX - Distant metastasis cannot be assessed
MO - No distant metastasis
M1 - Distant metastasis (exclude peritoneal metastasis)
Human
48
96
1.5mm
4um
8
12
Paraffin
Notes:
All tissues were fixed in 10% neutral buffered formalin for 24 hours and processed using identical SOPs. Sections were picked onto Superfrost Plus or Startfrost Adhesive slides. They all have a guaranteed six month shelf-life at 4C from the date of shipment. Additional cores not listed are orientation markers and have no data. There maybe <5% core loss per slide but the core retention rate should be >90%.
Bake at 60C for 30 minutes before use. If antigen retrieving is needed, it is always a good idea to start with a protocol with weak to mild strength. Please check our TNM guide as a reference. For IHC related information on products that provide them, please contact us at info@pantomics.com for the most up-to-date information.
For research use only. Designed for IHC or ISH based protein or RNA tissue profiling in evolution and progression of ovary cancers.
ARRAY POSITION | IMAGE | SEX | AGE | ANATOMIC SITE | PATHOLOGY | GRADE | STAGE (TNM) |
|---|---|---|---|---|---|---|---|
A01 | F | 40 | Ovary | Normal | |||
A02 | F | 27 | Ovary | Normal | |||
A03 | F | 19 | Ovary | Mucinous cystadenoma | |||
A04 | F | 61 | Ovary | Boderline mucinous cystadenoma | |||
A05 | F | 53 | Ovary | Thecoma | |||
A06 | F | 52 | Ovary | Thecoma | |||
A07 | F | 54 | Ovary | Thecoma | |||
A08 | F | 67 | Ovary | Thecoma | |||
A09 | F | 39 | Ovary | Thecoma | |||
A10 | F | 52 | Ovary | Granulosa cell tumor | |||
A11 | F | 43 | Ovary | Granulosa cell tumor | |||
A12 | F | 31 | Ovary | Teratoma | |||
B01 | F | 40 | Ovary | Normal | |||
B02 | F | 27 | Ovary | Normal | |||
B03 | F | 19 | Ovary | Mucinous cystadenoma | |||
B04 | F | 61 | Ovary | Boderline mucinous cystadenoma | |||
B05 | F | 53 | Ovary | Thecoma | |||
B06 | F | 52 | Ovary | Thecoma | |||
B07 | F | 54 | Ovary | Thecoma | |||
B08 | F | 67 | Ovary | Thecoma | |||
B09 | F | 39 | Ovary | Thecoma | |||
B10 | F | 52 | Ovary | Granulosa cell tumor | |||
B11 | F | 43 | Ovary | Granulosa cell tumor | |||
B12 | F | 31 | Ovary | Teratoma | |||
C01 | F | 56 | Ovary | Serous cystadenocarcinoma | II~III | T3N0M1 | |
C02 | F | 53 | Ovary | Serous cystadenocarcinoma | III | T3N0M1 | |
C03 | F | 45 | Ovary | Serous cystadenocarcinoma | III | T2N0M0 | |
C04 | F | 49 | Ovary | Endometrioid adenocarcinoma | III | T1N0M0 | |
C05 | F | 51 | Ovary | Serous cystadenocarcinoma | III | T1N0M0 | |
C06 | F | 44 | Ovary | Serous cystadenocarcinoma | III | T2N0M0 | |
C07 | F | 54 | Ovary | Serous cystadenocarcinoma | II~III | T3N1M1 | |
C08 | F | 74 | Ovary | Serous cystadenocarcinoma | III | T1N0M0 | |
C09 | F | 56 | Ovary | Serous cystadenocarcinoma | III | T3N0M1 | |
C10 | F | 54 | Ovary | Serous cystadenocarcinoma | III | T3N0M1 | |
C11 | F | 82 | Ovary | Endometrioid adenocarcinoma | II | T1N0M0 | |
C12 | F | 43 | Ovary | Endometrioid adenocarcinoma | I | T1N0M0 | |
D01 | F | 56 | Ovary | Serous cystadenocarcinoma | II~III | T3N0M1 | |
D02 | F | 53 | Ovary | Serous cystadenocarcinoma | III | T3N0M1 | |
D03 | F | 45 | Ovary | Serous cystadenocarcinoma | III | T2N0M0 | |
D04 | F | 49 | Ovary | Endometrioid adenocarcinoma | III | T1N0M0 | |
D05 | F | 51 | Ovary | Serous cystadenocarcinoma | III | T1N0M0 | |
D06 | F | 44 | Ovary | Serous cystadenocarcinoma | III | T2N0M0 | |
D07 | F | 54 | Ovary | Serous cystadenocarcinoma | II~III | T3N1M1 | |
D08 | F | 74 | Ovary | Serous cystadenocarcinoma | III | T1N0M0 | |
D09 | F | 56 | Ovary | Serous cystadenocarcinoma | III | T3N0M1 | |
D10 | F | 54 | Ovary | Serous cystadenocarcinoma | III | T3N0M1 | |
D11 | F | 82 | Ovary | Endometrioid adenocarcinoma | II | T1N0M0 | |
D12 | F | 43 | Ovary | Endometrioid adenocarcinoma | I | T1N0M0 | |
E01 | F | 52 | Ovary | Endometrioid adenocarcinoma | II | T1N0M0 | |
E02 | F | 44 | Ovary | Endometrioid adenocarcinoma | II~III | T1N0M0 | |
E03 | F | 51 | Ovary | Endometrioid adenocarcinoma | II | T1N0M0 | |
E04 | F | 51 | Ovary | Endometrioid adenocarcinoma | III | T1N0M0 | |
E05 | F | 71 | Ovary | Endometrioid adenocarcinoma | III | T3N0M1 | |
E06 | F | 58 | Ovary | Endometrioid adenocarcinoma | III | T3N0M1 | |
E07 | F | 50 | Ovary | Endometrioid adenocarcinoma | III | T1N0M0 | |
E08 | F | 39 | Ovary | Endometrioid adenocarcinoma | III | T2N0M0 | |
E09 | F | 54 | Ovary | Endometrioid adenocarcinoma | III | T3N0M1 | |
E10 | F | 68 | Ovary | Endometrioid adenocarcinoma | III | T1N0M0 | |
E11 | F | 38 | Ovary | Mucinous cystadenocarcinoma | I | T1N0M0 | |
E12 | F | 18 | Ovary | Mucinous cystadenocarcinoma | I | T1N0M0 | |
F01 | F | 52 | Ovary | Endometrioid adenocarcinoma | II | T1N0M0 | |
F02 | F | 44 | Ovary | Endometrioid adenocarcinoma | II~III | T1N0M0 | |
F03 | F | 51 | Ovary | Endometrioid adenocarcinoma | II | T1N0M0 | |
F04 | F | 51 | Ovary | Endometrioid adenocarcinoma | III | T1N0M0 | |
F05 | F | 71 | Ovary | Endometrioid adenocarcinoma | III | T3N0M1 | |
F06 | F | 58 | Ovary | Endometrioid adenocarcinoma | III | T3N0M1 | |
F07 | F | 50 | Ovary | Endometrioid adenocarcinoma | III | T1N0M0 | |
F08 | F | 39 | Ovary | Endometrioid adenocarcinoma | III | T2N0M0 | |
F09 | F | 54 | Ovary | Endometrioid adenocarcinoma | III | T3N0M1 | |
F10 | F | 68 | Ovary | Endometrioid adenocarcinoma | III | T1N0M0 | |
F11 | F | 38 | Ovary | Mucinous cystadenocarcinoma | I | T1N0M0 | |
F12 | F | 18 | Ovary | Mucinous cystadenocarcinoma | I | T1N0M0 | |
G01 | F | 48 | Ovary | Mucinous cystadenocarcinoma | I | T1N0M0 | |
G02 | F | 39 | Ovary | Mucinous cystadenocarcinoma | I | T3N0M1 | |
G03 | F | 23 | Ovary | Mucinous cystadenocarcinoma | I~II | T1N0M0 | |
G04 | F | 48 | Ovary | Serous cystadenocarcinoma | II | T1N0M0 | |
G05 | F | 53 | Ovary | Mucinous cystadenocarcinoma | II | T1N0M0 | |
G06 | F | 52 | Ovary | Clear cell carcinoma | II | T1N0M0 | |
G07 | F | 23 | Ovary | Endodermal sinus tumor | |||
G08 | F | 48 | Ovary | Endometrioid adenocarcinoma | III | T1N0M0 | |
G09 | F | 17 | Ovary | Dysgerminoma | |||
G10 | F | 37 | Ovary | Dysgerminoma | |||
G11 | F | 40 | Ovary | Metastatic colon signet ring cell carcinoma | |||
G12 | F | 17 | Ovary | Malignant teratoma | |||
H01 | F | 48 | Ovary | Mucinous cystadenocarcinoma | I | T1N0M0 | |
H02 | F | 39 | Ovary | Mucinous cystadenocarcinoma | I | T3N0M1 | |
H03 | F | 23 | Ovary | Mucinous cystadenocarcinoma | I~II | T1N0M0 | |
H04 | F | 48 | Ovary | Serous cystadenocarcinoma | II | T1N0M0 | |
H05 | F | 53 | Ovary | Mucinous cystadenocarcinoma | II | T1N0M0 | |
H06 | F | 52 | Ovary | Clear cell carcinoma | II | T1N0M0 | |
H07 | F | 23 | Ovary | Endodermal sinus tumor | |||
H08 | F | 48 | Ovary | Endometrioid adenocarcinoma | III | T1N0M0 | |
H09 | F | 17 | Ovary | Dysgerminoma | |||
H10 | F | 37 | Ovary | Dysgerminoma | |||
H11 | F | 40 | Ovary | Metastatic colon signet ring cell carcinoma | |||
H12 | F | 17 | Ovary | Malignant teratoma | |||
null |
